CCDC64 Inhibitors
Chemical inhibitors of CCDC64 encompass a variety of compounds that target different aspects of cellular signaling pathways, each with a unique mechanism of action that leads to the functional inhibition of the protein. Staurosporine and Go6983, for instance, are broad-spectrum kinase inhibitors that can prevent phosphorylation, a post-translational modification essential for the activation of many proteins, including CCDC64. Inhibition of phosphorylation impedes CCDC64's ability to perform its role within the cell. Similarly, Genistein targets tyrosine kinases, which, if involved in the activation of CCDC64, would lead to its inhibition by blocking the phosphorylation on tyrosine residues critical for CCDC64's function.
Further inhibiting the pathways upstream of CCDC64, LY294002 and Wortmannin specifically inhibit PI3K, a pivotal kinase in the PI3K/AKT pathway, which is integral to various cellular processes. By blocking PI3K, these inhibitors can suppress the downstream signaling required for CCDC64 activation. In the same vein, U0126 and PD98059 are selective for MEK1/2, which are upstream of the ERK pathway. Since ERK is often required for full protein functionality, inhibition by U0126 and PD98059 can result in the effective inhibition of CCDC64. SB203580 and SP600125 target other members of the MAPK pathway, namely p38 and JNK, respectively. These kinases, when inhibited, prevent the necessary signaling that might be required for the activity of CCDC64, leading to its functional inhibition. Rapamycin, on the other hand, acts on the mTOR pathway, a key regulator of cell growth and proliferation, and by doing so, can suppress the functions of CCDC64 if it is involved in these mTOR pathway-regulated processes. Finally, Brefeldin A disrupts protein trafficking within the cell by inhibiting ADP-ribosylation factor. If the activity of CCDC64 relies on specific cellular localization, Brefeldin A can inhibit its function by altering its trafficking and, consequently, its localization. These chemical inhibitors, through their targeted actions, collectively demonstrate the various pathways and mechanisms by which CCDC64 can be functionally inhibited.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. CCDC64 is known to be phosphorylated, and staurosporine can inhibit this phosphorylation, thus functionally inhibiting CCDC64. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3K) inhibitor. Since PI3K signaling is important for multiple cellular processes, inhibition by LY294002 can disrupt functions downstream, including those involving CCDC64, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can prevent the activation of pathways that CCDC64 may be involved in, functionally inhibiting the protein by blocking essential signaling required for its activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. By inhibiting MEK, U0126 can functionally inhibit CCDC64 by preventing the activation of the MAPK/ERK pathway, which is necessary for the full functionality of CCDC64. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor. If CCDC64 is involved in p38 MAPK-regulated processes, SB203580 can functionally inhibit CCDC64 by preventing its required phosphorylation events within this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which is involved in the MAPK/ERK pathway. By inhibiting this pathway, PD98059 can functionally inhibit CCDC64 if the protein requires MAPK/ERK signaling for its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAPK pathway. Functional inhibition of CCDC64 can occur if JNK signaling is necessary for the activity of CCDC64, as SP600125 would block this signaling cascade. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is involved in cell growth and proliferation. If CCDC64 function is connected to these processes, inhibition by Rapamycin can result in the functional inhibition of CCDC64 by blocking necessary signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. If tyrosine kinase activity is required for CCDC64 activity, Genistein can functionally inhibit CCDC64 by blocking its phosphorylation or the phosphorylation of associated proteins necessary for CCDC64's function. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a protein kinase C (PKC) inhibitor. If CCDC64 is regulated by PKC or its pathways, Go6983 can functionally inhibit CCDC64 by preventing PKC-mediated phosphorylation that would be necessary for CCDC64's activity. | ||||||